Suppression of choroidal neovascularization by N-acetyl-cysteine in mice

Current Eye Research

Volumn 35, Issue 11, 2010, Pages 1012-1020

  Hara, Ryuhei ^a   Inomata, Yasuya ^a   Kawaji, Takahiro ^a   Sagara, Nina ^a   Inatani, Masaru ^a   Fukushima, Mikiko ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

4 Hydroxy 2 nonenal modified protein; Age related macular degeneration; Choroidal neovascularization; N acetyl cysteine; Nucleus factor B; Oxidative stress; Vascular endothelial growth factor

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE FUNDUS; IMMUNOCHEMISTRY; LASER COAGULATION; MACROPHAGE MIGRATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; RETINA MACULA AGE RELATED DEGENERATION; STAINING; SUBRETINAL NEOVASCULARIZATION; WESTERN BLOTTING;

ACETYLCYSTEINE; ALDEHYDES; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CHEMOKINE CCL2; CHEMOKINE CXCL1; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICAL SCAVENGERS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; NF-KAPPA B; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77958458678     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.500112     Document Type: Article

References (45)

1. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology. 2004;111:1280-1287.
2. Lopez PF, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112:647-656.
3. Ambati J, Anand A, Fernandez S, et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003;9:1390-1397.
4. Zhou J, Pham L, Zhang N, et al. Neutrophils promote experimental choroidal neovascularization. Mol Vis. 2005;11: 414-424.
5. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119-126.
6. Imamura Y, Noda S, Hashizume K, et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of agerelated macular degeneration. Proc Natl Acad Sci U S A. 2006;103:11282-11287.
7. Li Q, Dinculescu A, Shan Z, et al. Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice. Mol Ther. 2008;16: 1688-1694.
8. Cai J, Nelson KC, Wu M, et al. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-221.
9. Dong A, Xie B, Shen J, et al. Oxidative stress promotes ocular neovascularization. J Cell Physiol. 2009;219:544-552.
10. Inomata Y, Tanihara H, Tanito M, et al. Suppression of choroidal neovascularization by thioredoxin-1 via interaction with complement factor H. Invest Ophthalmol Vis Sci. 2008;49:5118-5125.
11. Kim JW, No JK, Ikeno Y, et al. Age-related changes in redox status of rat serum. Arch Gerontol Geriatr. 2002;34:9-17.
12. Yamamoto M, Lidia K, Gong H, et al. Changes in manganese superoxide dismutase expression after exposure of the retina to intense light. Histochem J. 1999;31:81-87.
13. Aruoma OI, Halliwell B, Hoey BM, et al. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593-597.
14. Vecchiarelli A, Dottorini M, Pietrella D, et al. Macrophage activation by N-acetyl-cysteine in COPD patients. Chest. 1994;105:806-811.
15. Prescott LF. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs. 1983;25: 290-314.
16. Witschi A, Junker E, Schranz C, et al. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses. 1995;11:141-143.
17. Pinnen F, Cacciatore I, Cornacchia C, et al. Codrugs linking L-dopa and sulfur-containing antioxidants: New pharmacological tools against Parkinson's disease. J Med Chem. 2009;52:559-563.
18. Tanito M, Nishiyama A, Tanaka T, et al. Change of redox status and modulation by thiol replenishment in retinal photooxidative damage. Invest Ophthalmol Vis Sci. 2002;43:2392-2400.
19. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991;19:2499.
20. Inomata Y, Fukushima M, Hara R, et al. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice. Invest Ophthalmol Vis Sci. 2009.
21. Inomata Y, Nakamura H, Tanito M, et al. Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. J Neurochem. 2006;98:372-385.
22. Voghel G, Thorin-Trescases N, Farhat N, et al. Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev. 2008;129:261-270.
23. Winkler BS, Boulton ME, Gottsch JD, et al. Oxidative damage and age-related macular degeneration. Mol Vis. 1999; 5:32.
24. Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
25. Campochiaro PA, Soloway P, Ryan SJ, et al. The pathogenesis of choroidal neovascularization in patients with agerelated macular degeneration. Mol Vis. 1999;5:34.
26. Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefe's Arch Clin Exper Ophthalmol. 2004;242:91-101.
27. Cai T, Fassina G, Morini M, et al. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Lab Invest. 1999;79:1151-1159.
28. Morini M, Cai T, Aluigi MG, et al. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis. Int J Biol Markers. 1999;14:268-271.
29. Kruman I, Bruce-Keller AJ, Bredesen D, et al. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci. 1997;17:5089-5100.
30. Vallabhapurapu S, Karin M. Regulation and function of NFkappaB transcription factors in the immune system. Ann Rev Immun. 2009;27:693-733.
31. Yao H, Yang SR, Kode A, et al. Redox regulation of lung inflammation: Role of NADPH oxidase and NF-kappaB signalling. Biochem Soc Trans. 2007;35:1151-1155.
32. Hayashi T, Ueno Y, Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem. 1993;268: 11380-11388.
33. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1891-1898.
34. Sakurai E, Anand A, Ambati BK, et al. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:3578-3585. (Pubitemid 36909798)
35. Tsutsumi C, Sonoda KH, Egashira K, et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol. 2003;74: 25-32.
36. Yamada K, Sakurai E, Itaya M, et al. Inhibition of laserinduced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Invest Ophthalmol Vis Sci. 2007;48:1839-1843.
37. Itaya M, Sakurai E, Nozaki M, et al. Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest Ophthalmol Vis Sci. 2007;48:5677-5683.
38. Godavarthi SK, Narender D, Mishra A, et al. Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction. J Neurochem. 2009;108:787-795.
39. Nozaki M, Sakurai E, Raisler BJ, et al. Loss of SPARCmediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest. 2006;116:422-429.
40. Grisanti S, Tatar O. The role of vascular endothelial growth factor and other endogenous interplayers in agerelated macular degeneration. Prog Retin Eye Res. 2008;27: 372-390.
41. Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signalling- In control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359-371.
42. Sawano A, Iwai S, Sakurai Y, et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood. 2001;97:785-791.
43. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964-3972. (Pubitemid 29335849)
44. Tomita M, Yamada H, Adachi Y, et al. Choroidal neovascularization is provided by bone marrow cells. Stem Cells 2004;22:21-26.
45. Mochimaru H, Nagai N, Hasegawa G, et al. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2. Invest Ophthalmol Vis Sci. 2007;48: 4795-4801.